Abstract Background: Dialysis access should be timely, minimise complications and maintain functionality. The aim of the second combined vascular and peritoneal dialysis access audit was to examine practice patterns with respect to dialysis access and highlight variations in practice between renal centres. Methods: The UK Renal Registry collected centre-specific information on incident vascular and peritoneal dialysis access outcome measures in patients from England, Wales and Northern Ireland (EW&NI), including patient demographics, dialysis access type (at start of dialysis and three months after start of dialysis), surgical assessment and access functionality. Centres who had reported data on incident PD patients for the previous 2012 audit were additionally asked to provide one year follow up data for this group. The findings were compared to the audit measures stated in Renal Association clinical practice guidelines for dialysis access. Results: Fifty-seven centres in EW&NI (representing 92% of all centres) returned data on first access from 3,663 incident HD patients and 1,022 incident PD patients. A strong relationship was seen between surgical assessment and the likelihood of starting HD with an arteriovenous fistula (AVF). Twenty-four centres were at least two standard deviations below the 65% target for incident patients starting haemodialysis on AVF and only eight centres (14%) were within two standard deviations of the 85% target for prevalent haemodialysis patients on AVF. Conclusions: There was wide practice variation across the UK in provision of both HD and PD access which requires further exploration. 
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Introduction
The second combined vascular and peritoneal dialysis access audit in England, Wales and Northern Ireland represents the findings from the 2013 data collection period for patients starting dialysis between 1st January 2013 and 31st December 2013. Previously, vascular and peritoneal dialysis access audits have been published separately [1, 2] . The combined access audit provides information on timely and appropriate access interventions in order to achieve permanent access based on the recommendations and quality requirements stated in Renal Association clinical practice guidelines and Vascular Access guidelines for Haemodialysis and Peritoneal access [3, 4] . The core principal of these audits has been to highlight the performance variation of renal centres across England, Wales and Northern Ireland and explore factors that may contribute to the provision of excellent quality vascular and peritoneal access.
The term established renal failure used within this chapter is synonymous with the terms end stage renal failure and end stage kidney disease, which are in more widespread international usage. Patients have disliked the term 'end stage' which reflects the inevitable outcome of this disease.
Methods
All adult renal centres in England, Wales and Northern Ireland were contacted regarding vascular and peritoneal access for all incident and prevalent dialysis patients (centre level only) in 2013. Data were collected using Microsoft Excel spreadsheets circulated by the UK Renal Registry (UKRR). Of 62 centres contacted, data were received from 57 centres. Definitions were refined from the previous audit performed in 2013 based on the quality of the returned questionnaires and the feedback received from centres.
Patients who were identified by the renal centres as having acute kidney injury (AKI) in the free text fields or patients who were reported to have recovered renal function within three months were categorised as having AKI for the purposes of this audit and excluded (n = 367/5,105). The remaining records received were validated against the UKRR database to confirm that the population collected at each centre for the audit was the same as, or representative of, the incident population at that centre as collected via the usual UKRR quarterly return. Data checks were made by cross-referencing with the UKRR database. Any patients identified from the UKRR as not incident to dialysis between 1st January 2013 and 31st December 2013 were excluded. Similarly, where the reported prevalent numbers from the audit did not match those in the UKRR database, those centres were excluded. The cross-referencing also enabled ascertainment of information on mortality within three months of commencing dialysis.
Centres who reported data on peritoneal dialysis (PD) patients in the 2012 vascular and peritoneal access audit were asked to complete a one year follow up of their PD patients. Additional information was requested on the date of PD catheter failure, the reason for catheter failure, the number of catheters used during the year, and the modality in use at one year after starting PD. Table 10 .1 lists the summary of audit measures as stated in the Renal Association clinical practice guidelines, with explanation for why some of the audit measures were not reported.
Patients starting haemodialysis (HD) were grouped by type of first vascular access: arteriovenous fistula (AVF), arteriovenous graft (AVG), tunnelled dialysis line (TL), non-tunnelled dialysis line (NTL). Patients starting PD were categorised by the insertion technique: laparoscopic, peritoneoscopic, open surgery, percutaneous. Access at three months was defined as the type of access in use at three months after starting dialysis. If a patient was no longer receiving dialysis at three months then the reason was recorded instead, for example died or transplanted. Referral time was defined as the number of days between the date of first being seen by a renal physician and the date of commencing dialysis. Patients were classified as presenting late if they had a referral time of less than 90 days. In the analyses involving whether or not a patient had received surgical assessment at least three months before starting dialysis, patients were excluded if they were categorised as a late presenter.
Access failure was defined as the access no longer being usable for dialysis. Data about the date and cause of access failure were collected. Access failure was censored for death, transplantation, withdrawal from renal replacement therapy (RRT) and elective switching of access type. It was the intention to only capture access failures relating to the first type of access. If the reason recorded for access failure was incompatible with the first type of access recorded then the data was not included in this analysis.
Separate or combined analyses have been performed for incident HD patients and incident PD patients as appropriate. Due to the exploratory nature of the audit the analyses have been limited to descriptive statistics of frequencies, percentages and unadjusted associations between variables. If a centre had more than 50% missing returns for a particular data field, then all patients from the centre were excluded from analyses involving that data field. The data were analysed using SAS 9.3.
Results

Data completeness
Fifty-seven centres returned data on first dialysis access for 3,663 incident HD patients and 1,022 incident PD patients. The UKRR incident patient data for the same year were 4,030 HD and 1,108 PD, thus there were access returns on 91% of HD and 92% of PD patients.
Seventeen patients were excluded from all analyses due to missing RRT start date or first access type. Figure 10 .1 illustrates the data completeness for key variables. Variations in first dialysis access
Patient demographics
The median patient age when starting RRT was 67 years in the HD cohort and 60 years for patients commencing PD. Overall, 64.4% of the patients were male, 35.6% female; the proportional distribution of the sexes was similar for both the HD and PD subgroups.
A significant proportion of patients starting dialysis had diabetes (57.3%), however, diabetes associated nephropathy was the primary renal disease (PRD) in only 26.1% (table 10.2). .2 shows types of haemodialysis access stratified by age group. Patients aged less than 75 at the point of commencing RRT were less likely than older patients (575) to start dialysis using an AVF (39.6% vs. 43.5%) and more likely to start with a tunnelled line (39.6% vs. 31.5%). The reason for this is unknown but may reflect patient engagement with renal services or varying progression of chronic kidney disease in the older population. Figure 10 .3 shows haemodialysis access stratified by PRD. The proportional distribution of HD access modality was similar for different primary renal disease diagnoses. Of note, patients with polycystic kidney disease were more likely to start HD on an AVF. This likely results from the opportunity for timely access preparation as these patients are often known to renal Patients from centres with more than 50% missing data for a variable are excluded from the table for that variable AVF = arteriovenous fistula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line; GN = glomerulonephritis; BMI = body mass index; PKD = polycystic kidney disease; PRD = primary renal diagnosis; Pyelo = pyelonephritis; RVD = reno-vascular disease
Multisite dialysis access audit Nephron 2015;129(suppl1):223-245 services for many years before dialysis is required. Where no primary renal diagnosis was available, the numbers of patients starting dialysis with a tunnelled or nontunnelled dialysis venous catheter were higher, suggesting that this may represent a cohort of patients who present late to renal services or whose renal function declines more rapidly than predicted. (46.2%). The percutaneous approach was less likely to be used in patients in the higher BMI category (25.2%) compared with those with a lower BMI (29.5%). The peritoneoscopic or laparoscopic approach was used in a similar proportion of patients in both BMI groups. It should be noted that the analysis was limited due to a high proportion of missing data for BMI. Pyelonephritis (183) Hypertension (291) RVD (225) Diabetes (980) GN (430) Uncertain (517) No data (175) Other ( reported less than 10 patients using PD catheters for first dialysis in 2013. There continues to be a strong tendency for many centres to rely on one single approach to PD catheter placement, with 13 centres reporting use of a single technique for all of their patients. Twenty-two centres reported using the percutaneous technique. Amongst these centres were some of those with the highest proportion of patients using a PD catheter as first access (Derby 45.9%, London St Bartholemew's 39.5%, Wolverhampton 37.3%, Liverpool Roy 36.2%, to name a few).
First dialysis access and renal centre Figure 10 .6 shows type of first dialysis access by centre. Variations were apparent between centres when considering patients commencing dialysis via an AVF, ranging from 10% (London West, London St Bartholemew's, Wrexham) to 50% (Birmingham Heartlands, Cambridge, Colchester, Liverpool Aintree). Some centres had over 60% of patients starting dialysis on a tunnelled line (London West, Sunderland, Dudley). The use of arteriovenous graft as the first dialysis access was between 0-5% with only 17 of the 57 centres opting to use this.
Use of a PD catheter as first access varied between 45% (Derby) and 0% (Colchester, Clwyd, Dudley). In last year's audit there was some evidence that centres that had high usage of AVFs as starting access were also more likely to start patients on a PD catheter. Based on this year's audit, there is no evidence of this association.
The Renal Association guidelines on vascular access for Haemodialysis recommends 65% of all patients commencing haemodialysis should commence with an AV fistula. This is depicted in figure 10.7 with patients who presented late excluded for this analysis. There were 14 centres below 2 standard deviations and a further 10 centres below 3 standard deviations. There were two centres above 2 standard deviations (Derby, Liverpool Aintree). The results have to be cautiously interpreted due to non-adjustment for any patient related factors. This may indicate variation in local processes for access planning and delivery and needs further investigation. Figure 10 .8 shows a clear association between time known to a nephrologist and patient starting haemodialysis with an AVF. A greater proportion of patients who were known to a nephrologist for over one year started dialysis with an AVF, as compared to those who were referred between 90-365 days (42.5% vs. 25.3%). Similarly, patients who were known to a nephrologist between 90 days to over one year were more likely to start on PD when compared to patients who were referred ,90 days prior to dialysis start. Figure 10 .9 shows PD catheter insertion technique by referral time. Patients who were first seen by a nephrologist ,90 days before starting RRT were more likely to undergo percutaneous insertion when compared to patients who were known between 90-365 days and .365 days. Open surgical technique was less likely to be used in the patients presenting late when compared to the patients who were known over three months, probably because of having a lesser likelihood of seeing a surgeon. Figure 10 .10 shows first access for centres providing data for patients presenting late (known to renal services for ,90 days). Amongst the 913 patients for whom data were reported, 45.3% started dialysis on a tunnelled line, 38.1% on a non-tunnelled line, 11.6% using a PD catheter with only 4.8% having first access documented as an AVF. There was however, wide variation amongst centres and clearly an understanding of practice patterns could lead to potential improvements in access service provision. There may also be reporting differences which need to be explored.
First dialysis access and referral time
In 13 centres, more than 15% of patients presenting late had a peritoneal dialysis catheter inserted for use as first dialysis access and as a result had a lower requirement for tunnelled or non-tunnelled lines. However, the number of patients presenting late reported in some centres was extremely small and it is difficult to make firm observations about clinical pathways for the development of dialysis access in this cohort. Figure 10 .11 shows the type of haemodialysis access in patients known to the renal service for longer than three months. There was significant variation for patients starting haemodialysis on AVF, with Derby on one end of the spectrum at 91.6% and London West at the other end at 15%. The centres with highest tunnelled line use were London West (76%), Carlisle (73%), London St Bartholemew's (67%). There were five centres who reported over 30% of patients as starting on non-tunnelled lines despite being known to the centre for at least 90 days (Antrim 44.4%, Shrewsbury 41.6%, London Kings 37.7%, London St Georges 50.0%, Portsmouth 32.9%). It will be important to understand the variations in practice patterns that lie behind these statistics which were not provided by current data.
First dialysis access and surgical assessment Figure 10 .12 highlights the proportion of patients who had been referred for surgical assessment at least three months prior to starting dialysis. There was considerable Nottm (16) Stoke (14) Basldn (10) Salford (21) B QEH (55)
Leic (22) Prestn (23) Liv Ain (14) Dorset (15) Redng (27) York (9) Swanse (19) Stevng (31) Sheff (25) Oxford (29) Shrew (15) Camb (16) Hull (18) Middlbr (24) Brightn ( Fig. 10 .11. Type of first access for haemodialysis stratified by centre restricted to patients presenting to a nephrologist 590 days prior to start AVF = arteriovenous fistula; AVG = arteriovenous graft; TL = tunnelled line; NTL = non-tunnelled line 234 variation between the renal centres. Overall, the proportion referred to a surgeon was highest in Middlesbrough (97.5%), Cambridge (97%) and Gloucester (91.3%). A detailed understanding of factors that prevent patients from being assessed for access in a timely fashion is required. These may reflect organisational factors or clinical uncertainty around the need for dialysis.
Renal Association Peritoneal Access Clinical Guidelines state that [4]:
'Whenever possible, catheter insertion should be performed at least 2 weeks before starting peritoneal dialysis. Small dialysate volumes in the supine position can be used if dialysis is required earlier.' Figure 10 .13 shows the variation in centres according to whether PD catheters were inserted at least two weeks prior to commencing dialysis. Thirty of the 32 centres had over 40% of patients with their PD catheters inserted at least two weeks prior to commencement of dialysis. Nottingham, Belfast, Derby and Wolverhampton were 2 standard deviations below the mean, probably because these centres carry out PD catheter insertion in late presenters. This guideline was intended to reduce the risk of dialysate leakage following catheter insertion, however it may actually have resulted in patients being less likely to use the PD catheter for early start PD and therefore possibly be exposed to the hazards of a central venous line. It is quite possible that this guideline has been a disincentive to using PD for patients presenting late or for acute kidney injury and revision should be considered in the next iteration of the guideline.
In the 2013 audit returns a greater proportion of patients who received surgical assessment at least three months prior to commencing dialysis underwent open surgical insertion (53.3% vs. 39.2%) compared to those who did not ( figure 10.14) . Figure 10 .15 demonstrates a strong relationship between being assessed by a surgeon at least three months before starting dialysis and the likelihood of starting on an AVF. This relationship was much stronger than that between surgical assessment and method of PD catheter placement. This suggests that the role of surgical assessment was more important in relation to AVF placement. Of those assessed by a surgeon at least three months prior to starting dialysis, 73.5% started dialysis on an AVF whereas of those who were not seen by a surgeon only 10.1% did. Clearly, timely surgical assessment is a key component of the clinical pathway to fistula placement and without such assessment, patients are more likely to require temporary haemodialysis access such as a tunnelled or non-tunnelled dialysis catheter. The relationship between surgical assessment and AVF formation was very different from that of PD catheter placement. It is quite possible that the time required to plan PD catheter placement is less than that required for AVF formation where vein mapping may be necessary.
Dialysis access at three months after starting RRT
The type of access used three months after starting dialysis gives an important insight into the responsiveness of the access formation pathway. Table 10 .4 expresses the proportion of patients still dialysing using a particular form of access as a percentage of the access they originally started dialysis with. For example, 90.3% of patients starting dialysis with an AVF were still using this at three months and 88.4% of patients starting on PD remained on this modality at three months. Of patients starting dialysis via a tunnelled line, the majority continued to use this form of access at three months (76.4%) and of 775 patients who commenced dialysis via a non-tunnelled line, 492 (63.6%) were dialysing through a tunnelled line at three months. This may suggest that obtaining definitive access for HD within three months of starting treatment remains a challenge. Figure 10 .16 demonstrates the differences in access outcomes stratified by centre. By three months, 36% of patients were dialysing using an AVF (range 10% London West to 67% Colchester); 0.9% were using an AVG (0% many sites to 10% Exeter); 37% tunnelled lines (4% Liverpool Aintree to 79% London West); 3% nontunnelled lines; and 23% were using a PD catheter (0% Colchester, Basildon, Dudley to 44% Derby).
Access at 3 months in patients referred to renal centres ,90 days before starting dialysis was analysed. Only 41 centres were included in this analysis. The majority (71%) of patients presenting late were being dialysed using tunnelled lines at three months after dialysis start ( figure 10.17) . The between centre range was from 8% in Derby to 100% at Chelmsford and Sunderland. Amongst patients presenting late, only 11% were using an AVF at three months (individual centres ranged from 0% in nine centres to 42% in Exeter). PD catheters were used by 14% of patients (range 0% in 12 centres to 67% in Derby). It is interesting to note that in some centres late presentation is not always associated with poor start to a patient's dialysis pathway. These percentages must be interpreted with caution as reported numbers of patients presenting late tended to be low in many centres. Also further investigation is needed to review if patients who are dialysed via a tunnelled line at three months have a worse outcome compared to their counterparts who dialyse via AVF. Figure 10 .18 shows access in use at start of dialysis and at three months after commencing dialysis, displayed for all patients and also restricted to patients presenting late. There was a small increase in the proportion of patients dialysing with an AVF at three months for all patients (31.8% to 36.1%). The increase was higher in the late presenters from 4.8% to 11.2%. Use of a tunnelled line increased at three months in all patients (8.4%) and in late presenters (25.6%) respectively. This is clearly as a result of conversion from non-tunnelled line to tunnelled line. PD catheter use saw only a small increase for all patients (1.0%) and for late presenters (2.6%). Figure 10 .19 shows that the use of an AV fistula as the incident access was static between 2011and 2013, with the proportion reported as roughly 38% in each year. Use of an AV graft has fallen from 1.4% to 0.8% over the three year period. Reported use of a tunnelled line, non-tunnelled line and peritoneal dialysis catheter has been static.
Prevalent access
Five centres were excluded from the analysis as the reported prevalent access numbers did not match with the number of prevalent patients at each of the centres in the UKRR database.
The Renal Association guidelines on vascular access for haemodialysis recommends 85% of all prevalent patients on haemodialysis should dialyse using an AV fistula. Twenty-six centres were more than three standard deviations and five centres were more than two standard deviations below this target ( figure 10.20) . The results have to be again cautiously interpreted due to nonadjustment for any patient related factors. Figure 10 .21 shows type of dialysis access in prevalent patients by centre. Variations were apparent between centres when considering prevalent patients with an AV fistula, ranging from about 40% (Carlisle, Ipswich, London St Bartholemew's) to over 75% (Cambridge, Birmingham Heartlands, Truro). Three centres had over 40% of prevalent patients on a tunnelled or non-tunnelled line (Ulster, Ipswich, Belfast) with two centres (Derby, Truro) at the other end of the spectrum with less than 10% of patients. The use of an AV graft was between 0% and 12% with 35 centres opting to use this.
Use of a PD catheter in prevalent patients varied between 28% at Carlisle and 3% at Ulster (Colchester does not have any PD patients).
The percentage of prevalent patients using each type of dialysis access has not changed in the three years that the access audits have been collected ( figure 10.22) . Use of an AV fistula has been roughly 60% in each audit and use of PD has been approximately 15%.
Access failure Figure 10 .23 shows comparative access failure for the different access types within three months. Access failure was defined as a documented date of failure/discontinuation recorded within three months of starting dialysis unless a centre comment indicated that it was a planned discontinuation. But there were deficiencies in the way that failure was recorded in this audit. Failure rates were generally higher in the peritoneal dialysis group with failure rates for percutaneous and open surgery at 10.5% and 8.2% respectively. Failure rates were generally around 5% for haemodialysis access.
The number of access failures reported was small, however it can be seen from figure 10.24 that there was relatively poor reporting of the reason for failures. This may reflect the local documentation procedure. Infectious causes were reported as contributing to 10% of access failures of tunnelled lines and 0% for other haemodialysis accesses, and mechanical cause was reported as contributing to 90% of AVF failures. L Rfree (50) Wolve (15) Salford (19) Prestn (22) York (9) Donc (10) Stoke (10) B QEH (52) Leic (22) Redng (23) Wirral (6) Oxford (26) Sheff (23) Carlis (8) Stevng (29) Shrew (11) Dorset (15) Brightn (30) Leeds (31) Camb (16) Hull (17) Norwch (22) Middlbr (22) Exeter (24) B Heart (5)
Liv Roy (5) Bradfd (6) Cardff (12) L Kings (28) Basldn (8) Newc (14) Chelms (7) L Guys (14) Sund (7) Total ( Salford (479) Ipswi (152) Plymth (171) Hull (423) Wrexm (125) Notts (449) L Barts (1, 150) Brightn (488) Basldn (208) Chelms (159) York (172) Newry (109) Exeter (476) L Rfree (852) Glouc (246) Wirral (247) Dorset (318) Shrew (222) Cardff ( Again, numbers of PD access failure were small and hence drawing any inferences is difficult. However, it can be seen from figure 10.25 that peritoneoscopic technique had no documented failures within three months. Catheter related cause ranged from 53% to 70% of PD failure for each of the three other listed insertion techniques. Failure associated with leaks or hernia was highest for laparoscopic insertion. Twenty-seven out of 832 (3.25%) PD patients were reported as experiencing peritonitis within two weeks of catheter insertion (data not shown). This was significantly lower than the national target of 5%.
2012 PD access audit one-year follow-up Centres who reported on PD patients in the 2012 vascular and peritoneal access audits were asked to complete a one year follow up of their PD patients. The additional information requested was the date of catheter failure, the reason for catheter failure, the number of catheters used during the year, and the modality in use at one year after starting PD. Of 50 centres who reported data on PD patients in 2012, 28 completed the one year follow up, returning data on 522 (56%) patients.
In these patients, 290 (55.5%) were still on PD at one year with 88.3% of these (256/290) on their first catheter.
The majority of centres maintained .50% of patients on PD at one year, however only four centres maintained .80% on PD at one year. Modality change to haemodialysis varied from 0% (Antrim, Newry, Doncaster) to 43% (Sunderland, Chelmsford). For patients who started on PD in 2012, transplantation varied at centres from 0% to 55% (figure 10.26).
Causes of PD access failure within one year of starting on PD were analysed. The reported numbers were too low to draw firm conclusions. Unsurprisingly the principal causes of catheter failure were mechanical or infection related (figure 10.27). .28 is a funnel plot which graphically displays the unadjusted percentage of PD patients experiencing a catheter failure within one year of commencement of RRT across multiple renal centres. PD catheter failure was censored for transplantation, elective transfer to HD or death. The results have to be cautiously interpreted due to the extent of and variation in missing data, small numbers of patients in some centres and non-adjustment for any patient related factors.
Of the centres for which data were available (n = 17), no outlier centres were identified with failure rates above the upper 95% 'alert' or 99.9% 'alarm' limits for PD catheter failures. One renal centre reported one-year catheter failure rate below the 95% control limit. The mean one-year catheter failure rate was 17% which was below the rate recommended in the guidelines issued by the ISPD/RA (23% and 20% respectively).
Conclusions
This second multisite dialysis access audit from England, Wales and Northern Ireland has provided important information regarding the variation in access provision and failure. Data collection is still not optimal as significant amounts of missing data across a range of fields exist. Several operational definitions need to be refined for further audit collections. As over a fifth of haemodialysis patients start dialysis on a non-tunnelled line, it may be preferable to collect dialysis access at the fourth week as well as the first dialysis session since both non-tunnelled and tunnelled catheters are often used before more permanent access is placed (PD catheter, AVG or AVF). Of concern is that tunnelled lines continued to be used in approximately a third of patients three months post dialysis start and this figure was higher for patients presenting late. The practice of PD catheter insertion in patients presenting late was used by relatively few centres. Only 13 out of 43 centres with sufficient data on patients presenting late placed a peritoneal dialysis catheter in more than 15% of patients as first dialysis access. It was also interesting to note that in some centres late presentation was not always associated with poor start to a patient's dialysis pathway. Surgical assessment was key to formation of permanent vascular access (AVF/AVG), 73% started dialysis on an AVF whereas of those who were not seen by a surgeon only 10% did. Twenty-four centres were 2 or 3 standard deviations below the 65% target for incident patients starting haemodialysis on AVF and 31 centres were below the 85% target for prevalent haemodialysis patients on AVF. The vascular access clinical practice guidelines are due for review this year and the authors need to reconsider whether these current standards should be changed. Further analyses are being planned to explore why there is such a wide variation in access provision between centres and whether the type of vascular access in use at dialysis start explains the different outcomes.
